Barde, Yves - Cardiff University - School of Biosciences

个人简介

Our work focuses on secreted molecules designated neurotrophins. These molecules play critical roles in the development of the vertebrate nervous system and the maintenance of its function in the adult (for a recent review of some of their properties, see Dekkers et al. 2013). The dominant neurotrophin in the CNS is brain-derived neurotrophic factor (BDNF). It is encoded by a gene regulated by neuronal activity and both human genetics and animal models illustrate its relevance in, for example, memory consolidation and neuroprotection. We now explore the possibility that BDNF may regulate not only the function, but also the growth and function of neurons in the adult brain, either from within the brain or from sources outside the brain. Indeed, our laboratory recently identified megakaryocytes as a major source of BDNF in humans, in collaboration with the group of Cedric Ghevaert at the University of Cambridge (see Chacon-Fernandez et al. 2016). We are also interested in using small molecules diffusing into the brain with the goal of increasing BDNF levels so as to help preventing neuronal dysfunction (see Deogracias et al. 2012). Our laboratory extensively uses both mouse and human embryonic stem cells to generate neurons. This represents a powerful tool that based on the use of differentiated mouse embryonic stem cells allowed us to uncover new roles for the transcription factor Pax6 (Nikoletopoulou et al., 2007), the amyloid precursor protein APP (Schrenk-Siemens et al. 2008), the neurotrophin receptors p75 (Plachta et al. 2007; Bischoff et al. 2012), TrkA and TrkC (Nikoletopoulou et al. 2010) and MeCP2, the gene most frequently mutated in Rett syndrome (Yazdani et al. 2012).

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Binley, K.et al. 2016. Brain-derived neurotrophic factor prevents dendritic retraction of adult mouse retinal ganglion cells. European Journal of Neuroscience 44, pp. 2028-2039. (10.1111/ejn.13295) pdf Chacon Fernandez, P.et al. 2016. Brain-derived neurotrophic factor in megakaryocytes. Journal of Biological Chemistry 291(19), pp. 9872-9881., article number: jbc.M116.720029. (10.1074/jbc.M116.720029) pdf Sirko, S.et al. 2015. Astrocyte reactivity after brain injury-: The role of galectins 1 and 3. Glia 63(12), pp. 2340-2361. (10.1002/glia.22898) pdf Dekkers, M. p. J., Nikoletopoulou, V. and Barde, Y. 2013. Death of developing neurons: New insights and implications for connectivity. Journal of Cell Biology 203(3), pp. 385-393. (10.1083/jcb.201306136) pdf Dekkers, M. P. J. and Barde, Y. 2013. Programmed cell death in neuronal development. Science 340(6128), pp. 39-41. (10.1126/science.1236152) Yazdani, M.et al. 2012. Disease modeling using embryonic stem cells: MeCP2 regulates nuclear size and RNA synthesis in neurons. Stem Cells 30(10), pp. 2128-2139. (10.1002/stem.1180) Deogracias, R.et al. 2012. Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome. Proceedings of the National Academy of Sciences of the United States of America 109(35), pp. 14230-14235. (10.1073/pnas.1206093109) Tiwari, V.et al. 2012. Target genes of Topoisomerase IIβ regulate neuronal survival and are defined by their chromatin state. Proceedings of the National Academy of Sciences of the United States of America 109(16), pp. E934-E943. (10.1073/pnas.1119798109) Dieni, S.et al. 2012. BDNF and its pro-peptide are stored in presynaptic dense core vesicles in brain neurons. Journal of Cell Biology 196(6), pp. 775-788. (10.1083/jcb.201201038) pdf Bischoff, V.et al. 2012. Seizure-induced neuronal death is suppressed in the absence of the endogenous lectin galectin-1. Journal of Neuroscience 32(44), pp. 15590-15600. (10.1523/JNEUROSCI.4983-11.2012) pdf Bischoff, V., Nikoletopoulou, V. and Barde, Y. 2011. Sauver ou tuer. Médecine Sciences M/S 27(2), pp. 119-121. (10.1051/medsci/2011272119)